Taxol, a mitotic spindle toxin, was found to selectively inhibit the proliferation of Leishmania donovani in vitro at nanomolar concentrations with an IC 50 of 35 nM. Concentrations of taxol as high as 50 nM, however, did not affect J774A.1 murine macrophages. Taxol (30 nM) also inhibited amastigote multiplication within a J774A.1 macrophage cell line when used in a 10-day experiment. It resulted in the in vitro assembly of L. donovani microtubules in a dose-dependent manner. When promastigotes were exposed to different concentrations of taxol for 24 h, cells were largely blocked in the G 2 -M phase of the cell cycle and there was a marked reduction in the percentage of cells in the S phase. The selective nature of taxol action against the parasite and its effectiveness in controlling amastigote multiplication emphasise its use as a promising chemotherapeutic against kala-azar. ß
Introduction
Leishmania donovani is a protozoan parasite that causes visceral leishmaniasis. Globally, millions of people are infected with this parasite and options for drug treatment are limited primarily to antimonial drugs. The high toxicity of these drugs makes alternative approaches attractive. In addition, the development of resistance is a grave concern as it is further accentuated by the small range of antileishmanial drugs. There is an urgent need for new molecular targets against which we can design new and more e¡ective drugs. Since tubulin is the most abundant leishmanial protein, perhaps the microtubule inhibitory agents can serve as antileishmanial compounds.
Taxol is a mitotic spindle toxin isolated from the bark of the Paci¢c yew Taxus brevifolia and is a naturally occurring chemotherapeutic against cancer [1] . While the exact mechanism of taxol cytotoxicity is unclear, there is evidence that its antitumor e¡ect results from its binding tightly to microtubules and preventing their disaggregation [2, 3] . Taxol blocks the transition of cycling cells from the late G 2 to M phase of the cell cycle [4] .
Earlier reports have shown that taxol is e¡ective in blocking the replication of Trypanosoma cruzi para-sites [5] and is also e¡ective against drug-resistant Trypanosoma strains [6] . Taxol is also known to have an e¡ect on the cell cycle and cytoskeleton of L. donovani promastigotes [7] . In this paper we explore the e¡ect of taxol on L. donovani promastigotes and amastigotes in vitro and its mechanism of action. Taxol, at nanomolar concentrations, was found to selectively inhibit the proliferation of L. donovani promastigotes as well as the multiplication of amastigotes within J774A.1 macrophages in vitro. The e¡ects of taxol on host macrophages, on the cell cycle of Leishmania promastigotes and on tubulin assembly in these promastigotes in vitro are also reported.
Materials and methods

Chemicals and parasites
Powdered media RPMI 1640 and M-199 were purchased from Sigma Chemical Co., St. Louis, MO, USA. Minimal essential medium with alpha modi¢-cation (K-MEM) was procured from Gibco, USA. Foetal calf serum (FCS) was obtained from Biological Industries, Israel. Taxol, propidium iodide, MES (2[N-morpholino] ethane sulfonic acid) and L-mercaptoethanol were also obtained from Sigma Chemical Co. All other chemicals were purchased locally and were of analytical grade.
Freshly transformed promastigotes of L. donovani (strain AG83) (MHOM/IN/1983/AG83) were used in this study [8] . They were suspended in minimal essential medium (K-MEM) prior to use in the drug studies and in RPMI 1640 medium containing 10% FCS (RPMI) for use in the amastigote multiplication assay.
E¡ect of taxol on promastigote growth
Taxol was dissolved in methanol and ¢lter-sterilised before addition to the medium containing parasites. The toxicity of the drug was determined by adding a range of drug concentrations (0^100 nM) to a suspension of promastigotes (1U10 6 cells ml 31 ) and incubating them at 22³C for 48 h. The minimum concentration of the drug that caused inhibition of approximately 50% of the parasites at 48 h of drug treatment was designated IC 50 [8] . The time-dependent e¡ect of the inhibitor was determined by adding the inhibitor to the promastigote suspension at 24 h after plating in K-MEM medium and determining the cell density after every 24 h until 120 h. Triplicate incubations in the absence of drug were maintained in parallel as controls. The protozoal counts were taken using a Neubauer haemocytometer.
2.3. E¡ect of taxol on J774A.1 macrophages J774A.1 macrophages were plated onto petri dishes at a density of 1U10 6 cells per plate and incubated at 37³C in a CO 2 incubator (5% CO 2 ) for 24 h. Taxol was added at this stage and the macrophages were incubated for another 48 h at 37³C. The cells were then harvested by trypsinisation and the number of live cells in each set was determined using the trypan blue dye exclusion test. The results were expressed as percentage of cells in control cultures of triplicate samples.
E¡ect of taxol on intracellular amastigote multiplication
J774A.1 macrophages were plated onto adherent petri dishes at a cell density of 1U10 6 cells ml 31 and incubated overnight at 37³C in a CO 2 incubator (5% CO 2 ). Parasites were added onto the macrophages at a ratio of 10:1 and the plates were re-incubated at 37³C for 3 h. After 3 h, the excess promastigotes were washed o¡ and the plates were incubated at 37³C for another 12 h to enable transformation of promastigotes to amastigotes. At this stage, the drug was added to the plates and they were kept at 37³C. The drug was replenished on days 3, 5 and 7. On day 10, the plates were harvested for microscopic examination after staining with Giemsa. The data were expressed as the percentage of infected macrophages þ S.D. and the mean number of amastigotes per 100 infected macrophages þ S.D. Each data point represents mean þ S.D. of triplicate samples [9] .
E¡ect of taxol on the cell cycle of leishmanial promastigotes
Exponential phase AG83 promastigotes were treated with di¡erent concentrations of taxol at 22³C for 24 h. 2U10 6 cells were harvested after 24 h, ¢xed in 70% ethanol and stored at 4³C. Before the assay, the ethanol was removed by centrifugation. The cells were stained with 1 ml propidium iodide staining solution (50 Wg ml 31 PI, 100 Kunitz units RNase A and 1 mg ml 31 glucose in PBS without Ca 2 or Mg 2 ) and incubated for 30 min at room temperature with constant shaking. The cells were examined within 12 h using EPICS 0 XL-Software (Coulter, Miami, FL, USA) and then analysed using MULTICYCLE Software (Phoenix Flow Systems, K-OS Un Ltd. Inc., USA) [10] . These experiments were performed twice.
E¡ect of taxol on tubulin assembly in vitro
AG83 promastigotes were harvested from 200-ml cultures, washed with PBS and re-suspended in phosphate glutamate bu¡er (PG: 20 mM NaHPO 4 , 100 mM glutamic acid, 1 mM L-mercaptoethanol, adjusted to pH 7.0 with 1 mM NaOH), PMSF (10 Wg ml 31 ) and Triton X-100 (0.5% w/v) were added to the PG bu¡er and the cells were homogenised. Detergent-insoluble cytoskeleton was collected, washed in PG-PMSF (3U), frozen in liquid nitrogen and stored at 370³C according to the method of Chan and Fong [11] . The pellet was thawed on ice and resuspended in 1 ml MEMED bu¡er (100 mM MES pH 6.7, 1 mM EGTA, 1 mM MgSO 4 , 1 mM EDTA and 1 mM DTT). GTP (2 mM) and MgCl 2 (1 mM) were added to the above solution and it was sonicated for 20 s (7U) to release the cytoskeletal proteins with 1 min cooling on ice after each sonication and a liquid nitrogen freeze-thaw after the third sonication. The solution was centrifuged and the supernatant was collected. It was assayed for protein using the micro Lowry method [12] . In vitro microtubule polymerisation was measured by incubating tubulin samples (0.8 mg ml 31 ) with di¡erent concentrations of taxol and measuring the absorbance in a temperature-controlled spectrophotometer at 37³C [1, 2, 5] . The absorbance was measured at 30-s intervals for a period of 1 min. Since the maximum assembly was observed within 30 s, the maximum absorbance value at this time point was used for making the graph.
In addition to leishmania preparations, microtubules from a mammalian source, rodent brain, were used as control. Freshly collected brains from rats were homogenised in MES-EGTA-guanosine 5P-triphosphate bu¡er (0.1 M MES, 1 mM EGTA, 1 mM GTP, 0.5 mM MgCl 2 (pH 6.4) at 4³C [13] . The minced tissue was washed twice with this bu¡er and homogenised in 1 ml of bu¡er per g of tissue. The homogenate was centrifuged at 100 000Ug for 1 h at 4³C and the tubulin was prepared by two cycles of assembly-disassembly and stored at 320³C in MES bu¡er (0.1 M MES, 1 mM EGTA, 0.5 mM MgCl 2 , adjusted to pH 6.4 with NaOH) containing 1 mM GTP and 4 M glycerol [13] . Before the experiment, tubulin was dialysed for 3 h at 4³C against 100 volumes of MES bu¡er and centrifuged at 120 000Ug for 20 min at 4³C. The fraction was quantitated for protein and the assembly was monitored using 0.8 mg ml 31 of tubulin and di¡erent concentrations of taxol as described above for the leishmanial tubulin. The absorbance was measured at 50-s interval for a period of 10 min. Since the maximum assembly was observed at 5 min in this case, the maximum absorbance value at this time point was used for making the graph.
All results are means þ S.D. of triplicate samples at each time point. Student's t-test was performed to determine the level of signi¢cance and P 6 0.05 was regarded as signi¢cant. Table 1 E¡ect of taxol on intracellular amastigote multiplication of L. donovani within host macrophages in vitro 
Results
Taxol was found to inhibit leishmanial growth with an IC 50 of 35 nM. A concentration of 100 nM inhibited promastigote growth completely (Fig.  1) . The drug kinetics of taxol on AG83 promastigotes over a period of 48 h is shown in Fig. 2 . Maximum inhibition was observed 24 h after drug addition (Fig. 2) . Taxol also resulted in morphological changes like cell rounding of the parasite as observed under the phase contrast microscope. The organisms continued to exhibit motility. Table 1 shows the e¡ect of taxol on intracellular amastigote multiplication within J774A.1 murine macrophages. A concentration of 20 nM reduced the percentage infectivity signi¢cantly (P 6 0.001) but it had no signi¢cant e¡ect on amastigote numbers. A 30 nM concentration, however, reduced both parameters in a signi¢cant manner (P 6 0.01^0.001).
Taxol was also tested on host macrophages in order to determine the selectivity of its action on promastigotes. Fig. 3 shows the e¡ect of di¡erent concentrations of taxol on J774A.1 host macrophages at 48 h of macrophage treatment. A 50 nM concentration of taxol, which reduces promastigote number to 30% of control values, resulted in a 77% survival of J774A.1 macrophages. Higher concentrations of taxol (100 nM, 500 nM and 1000 nM) resulted in 57%, 44% and 28% survival respectively of J774A.1 macrophages.
The di¡erential e¡ect of taxol against the parasite and the host macrophages led us to examine the mechanism of action of this compound. Since taxol has been found to arrest cancer cells in the G 2 -M phase of the cell cycle, we studied the e¡ect of taxol on the cell cycle of AG83 promastigotes. A range of taxol concentrations from 1 nM to 10 nM was tried and cells were harvested at 24-, 48-and 72-h intervals after drug treatment. PI staining followed by £ow cytometry showed that there was a signi¢cant blockage of cells in the G 2 -M phase of the cell cycle and the percentage of cells in S phase decreased signi¢cantly at 24 h of treatment in taxol-treated cells. Higher concentrations of taxol, 5 nM and 10 nM, did not further alter the cell cycle pattern when compared to 1 nM (Table 2) .
Taxol has been shown to bind to the microtubules in cancer cells. Thus, we used this compound in binding assays with leishmanial tubulin. Tubulin was extracted from AG83 promastigotes [6, 14] . A range of taxol concentrations was added and tubulin assembly was monitored at 30-s intervals for a period of 1 min per sample [1] . Taxol caused an increase in the absorbance and hence tubulin assembly within 30 s of addition; after this there was no further increase in the absorbance. Since there was no further increase in the turbidity 30 s after taxol addition, the dose-dependent e¡ect of taxol on tubulin assembly depicted here is at the 30-s time point for all concentrations used. Concentrations ranging from 0.1 to 0.5 WM showed a dose-dependent increase in tubulin assembly. Higher concentrations did not lead to any further increase in tubulin assembly (Fig. 4A) . These data con¢rm that taxol mediates its e¡ect on AG83 promastigotes by binding to the microtubules. In the case of rat brain, a range of taxol concentrations was added and tubulin assembly was monitored at 50-s intervals for a period of 10 min per sample [1] . The dose-dependent e¡ect depicted here is at the 5-min time point for all the concentrations used. Concentrations ranging from 0.1 to 0.5 WM showed a dose-dependent inhibition of tubulin assembly (Fig. 4B) .
Discussion
The parasite L. donovani exists in two forms^a Fig. 4 . E¡ect of taxol on microtubule assembly in vitro. L. donovani and rat brain tubulin were prepared as described in Section 2. Microtubule polymerisation was measured in vitro by incubating 0.8 mg ml 31 of tubulin sample with di¡erent concentrations of taxol and the turbidity measurements were made at 350 nm at 30 s after taxol addition in the case of leishmanial tubulin and 5 min after taxol addition in the case of rat brain tubulin, using a Gilford spectrophotometer equipped with an automatic recorder and a thermostatically regulated sample chamber. A: Turbidity measurement at 30 s after taxol addition to the leishmanial tubulin samples. B : Turbidity measurement at 5 min after taxol addition to the rat brain tubulin. £agellated, motile, extracellular promastigote form that survives within the salivary glands of the Phlebotomine sand£y vector and a nonmotile, intracellular amastigote form that exists within the macrophages of the vertebrate host. Antimonials are currently the only viable options for drug treatment. However, the high toxicity of these drugs and the emergence of resistance render chemotherapy di¤-cult. Hence there is an urgent need for novel chemotherapeutic agents against kala-azar. Since tubulin is one of the most abundant leishmanial proteins, microtubule inhibitory agents may provide e¡ective chemotherapeutics. Previous reports have shown the antileishmanial e¡ects of two such agents^tri-£uralin [11] and oryzalin [14] . Both these drugs prevent microtubule assembly. They have also been found to act selectively on the parasite and do not a¡ect the host cells.
Taxol is a cancer chemotherapeutic which binds to tubulin and prevents disassembly of microtubules [2, 3] , thereby blocking cells in the G 2 -M phase of the cell cycle [4] . Taxol has been used previously against T. cruzi and L. donovani promastigotes and it has been found to block replication of the parasite at micromolar concentrations [5, 7] . Drug-treated parasites were found to have multiple cell organelles but they could not divide fully, con¢rming that taxol causes inhibition of microtubule disassembly in these cells [5] .
In the present study taxol inhibited leishmanial growth at nanomolar concentrations. It also inhibited infectivity and amastigote multiplication within a J774A.1 murine macrophage cell line. When taxol was used against J774A.1 cells, it was found that it had a selective action against the parasite. A 100 nM concentration of taxol resulted in complete inhibition of parasite growth whereas concentrations of taxol up to 500 nM resulted in only 56% inhibition of the macrophage growth (a concentration 14 times the IC 50 value for the parasite). Treatment of promastigotes with taxol at di¡erent time intervals was found to arrest cells in the G 2 -M phase of the cell cycle and inhibited the percentage of cells in the S phase signi¢cantly. Earlier work by Moulay et al. [7] also showed that taxol interferes with G 2 -M progression in L. donovani promastigotes.
In order to con¢rm the mechanism by which taxol exerts its e¡ect, in vitro tubulin binding assays with taxol were performed. Taxol increased leishmanial tubulin assembly at 37³C in a cell-free system in a dose-dependent manner. In contrast, taxol in the rat brain acted as an inhibitor of tubulin assembly in vitro. Thus, it appears that in vitro, the mechanism of action of taxol on leishmanial tubulin is di¡erent from that on the mammalian tubulin. These results show that taxol binds to leishmanial tubulin in vitro and that it may be important for cytoskeleton-targeted chemotherapy against visceral leishmaniasis.
